Aminoacyl‐ tRNA Synthetases: Variant Classification, Functional Assays, and Emerging Therapeutic Strategies
Journal of Inherited Metabolic Disease · 2026-05 · 49 (3)
DOI: 10.1002/jimd.70184 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 24.04.2026. Verfasst von M I Mendes und 17 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Genetic Metabolic Diseases, Department of Laboratory Medicine, Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Amino Acyl-tRNA Synthetases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aminoacyl‐tRNA synthetases (aaRS) are essential enzymes that charge tRNAs with their corresponding amino acids, playing a critical role in protein synthesis. All 37 nuclear‐encoded ARS genes, comprising both cytosolic ( ARS1 ) and mitochondrial ( ARS2 ) isoforms, have now been linked to human disease. Pathogenic variants in these genes cause a wide range of phenotypes, from dominant peripheral neuropathies to recessive multisystemic disorders. Despite the high number of ARS variants identified, functional validation remains difficult, with over 80% of missense variants classified as VUS in public databases. Additionally, the role of non‐canonical aaRS functions in disease remains an area requiring further exploration. Our laboratory developed a high‐throughput LC–MS/MS‐based aminoacylation assay to measure aaRS activity in patient‐derived fibroblasts, aiding in variant classification. This functional approach has contributed to the diagnosis of nearly 200 patients and has uncovered complex variant effects, including thermolabile and splicing‐defective forms. Therapeutically, amino acid supplementation and dietary interventions have shown effect in select cases, while gene therapy is being explored for dominant ARS‐related neuropathies. Amenability to targeted interventions further underlines the need for correct interpretation of genetic variants, which are increasingly recognized as genetic testing is progressively used in the diagnostic work‐up and functional assays. Additionally, natural history studies are essential to improve diagnosis, understand disease mechanisms, and guide and evaluate personalized treatment. This review underscores the critical need for integrated genomic and functional approaches to advance variant interpretation and therapeutic development in the era of NGS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory Genetic Metabolic Diseases, Department of Laboratory Medicine, Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands.
- Amsterdam Gastroenterology Endocrinology and Metabolism (AGEM), Amsterdam, the Netherlands.
- Department of Pediatrics, Division of Metabolic Diseases, Amsterdam UMC Location University of Amsterdam, Emma Children's Hospital, Amsterdam, the Netherlands.
- Amsterdam Cardiovascular Sciences Institute, Amsterdam, the Netherlands.
- Department of Child Neurology, Emma's Children's Hospital, Amsterdam UMC Location Vrije Universiteit, Amsterdam, the Netherlands.
- Amsterdam Leukodystrophy Center, Amsterdam Neuroscience, Cellular & Molecular Mechanisms, Amsterdam, the Netherlands.
ORCID-Profile: A M Bosch, S A Fuchs, I U Heinemann, S Kemp, M Langeveld, N I Wolf
Zitieren
APA
Mendes, M. I., Smith, D. E., Spek, V., Bosch, A. M., Corpeleijn, W. E., Engelen, M., Fuchs, S. A., Hadchouel, A., Heinemann, I. U., Houtkooper, R. H., Hoytema van Konijnenburg, E. M. M., Kemp, S., Langeveld, M., Karnebeek, C. D. M., Pop, A., Siu, V. M., Wolf, N. I., & Salomons, G. S. (2026). Aminoacyl‐ tRNA Synthetases: Variant Classification, Functional Assays, and Emerging Therapeutic Strategies. Journal of Inherited Metabolic Disease, 49(3). https://doi.org/10.1002/jimd.70184
Vancouver
Mendes MI, Smith DE, Spek V, Bosch AM, Corpeleijn WE, Engelen M, et al. Aminoacyl‐ tRNA Synthetases: Variant Classification, Functional Assays, and Emerging Therapeutic Strategies. Journal of Inherited Metabolic Disease. 2026;49(3). doi:10.1002/jimd.70184
BibTeX
@article{Mendes2026,
author = {Mendes, M I and Smith, D E and Spek, V and Bosch, A M and Corpeleijn, W E and Engelen, M and Fuchs, S A and Hadchouel, A and Heinemann, I U and Houtkooper, R H and Hoytema van Konijnenburg, E M M and Kemp, S and Langeveld, M and Karnebeek, C D M and Pop, A and Siu, V M and Wolf, N I and Salomons, G S},
title = {Aminoacyl‐ tRNA Synthetases: Variant Classification, Functional Assays, and Emerging Therapeutic Strategies},
journal = {Journal of Inherited Metabolic Disease},
year = {2026},
volume = {49},
number = {3},
doi = {10.1002/jimd.70184}
}
EUVIMED